Share this
Merus Enters Collaboration With Eli Lilly to Develop New Generation of Cancer Treatments
Hansa Biopharma Announces Collaboration with Sarepta
Poseida Therapeutics – $224 Million IPO
Therachon Sells to Pfizer for up to $810 Million
Lodo Therapeutics Enters $970 Million Multi-Target Collaboration With Genentech
Selecta Biosciences – $74 Million IPO
AveXis – $95 Million IPO
Cardioxyl Pharmaceuticals sale to Bristol-Myers Squibb
NewLink Will License Ebola Vaccine to Merck
FORMA $600 Million Collaboration with Celgene
TYRX: Acquired by Medtronic
Two Independent Billion-Dollar Life Sciences Collaborations
Apollo Endosurgery Agreement Acquire Obesity Intervention Division of Allergan
FORMA Therapeutics $200M Strategic Collaboration Deal with Celgene
Cylex Use Chapter 11 Bankruptcy to Achieve Exceptional Sale Price